ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 627986 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 627986; 2) Community: the network communities that were significantly associated with the response to NSC 627986; 3) Molecule: the relationships between components within communities and NSC 627986; 4) MDR: the compounds that were significantly associated with the NSC 627986.

NSC Compound Enrichment Correlation
NSC 286122 Null 0.0376362543535815 0.1160545
NSC 328403 Acetamide, N-(4-formyl-5,6,7,9-tetrahydro-1,2,3,10- tetramethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0376362543535815 0.20809259
NSC 622926 Null 0.0376362543535815 0.031024828
NSC 321521 SK&F 39162 0.038267585766958 -0.019256116
NSC 137765 Ethanesulfonic acid, compd. with 3-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)-N-phenylbenzeneacetamide (1:1) 0.0382675857669585 0.080117689
NSC 150094 1-Azabicyclo[2.2.2]octan-3-one, 2-(4-morpholinylmethyl)- 0.0382675857669585 -0.039394602
NSC 172599 7H-Pyrrolo[2,3-d]pyrimidine-5-carbonitrile, 4-amino-6-hydrazino-7-.beta.-D-ribofuranosyl- 0.0382675857669585 -0.0017254532
NSC 338947 Clomesone 0.0382675857669585 0.33754087
NSC 356777 2-Propen-1-one, 3-(4-chlorophenyl)-1-(1-hydroxy-7-oxo- 1,3,5-cycloheptriene-2-yl)- 0.0382675857669585 0.13781876
NSC 363979 Cephalostatin 1 0.0382675857669585 0.17732174
Total:39  Current:30    [First] [Prev] [Next] [Last]